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Follicular dendritic cells (FDCs) are important for the
induction of protective T cell-dependent humoral
responses, but their contribution to autoimmunity
remains elusive. Here, gene-targeted interruption of
FDC development was combined with the K/BxN
mouse model of arthritis. We found that FDCs were
essential for autoantibody production through two
distinct but cooperative functions. In a T cell-inde-
pendent fashion, FDCs loaded with autoantigen-
containing immune complexes supported germinal
center (GC) B cell development. Additionally, the
integrity of FDC networks was required for the
recruitment of arthritogenic follicular helper T cells,
a process that drove T-B cell interactions and
productive GC reactivity. Importantly, pharmacolog-
ical interference in the maintenance of FDCs amelio-
rated disease development, suggesting the FDC as
a potential target for dampening autoimmunity.
INTRODUCTION
Follicular dendritic cell (FDC) networks have a prominent role on
the structure of primary and secondary lymphoid follicles and are
the major follicular source of the chemokine CXCL13. FDCs
promote the assembly of primary lymphoid follicles through the
recruitment of naive CXCR5-bearing B cells to their vicinity (Allen
et al., 2004; Ansel et al., 2000; Forster et al., 1996). During
germinal center (GC) reactions, FDCs trap large amounts of
immune complexes via complement and Fc receptors, providing
niches for antigen engagement and selection of B cells with
respect to the specificity and the affinity of B cell receptor
(MacLennan, 1994; Qin et al., 1998, 2000; Tew et al., 1997). In
addition, CXCL13-producing FDCs convene CXCR5hi follicular
helper T (Tfh) cells to ensure that GC B cells will receive T cell
help required for the progression of GC B cell responses (Ansel
et al., 1999; Breitfeld et al., 2000; Estes et al., 2004; Kim et al.,
2001; Nurieva et al., 2008; Schaerli et al., 2000; Vogelzang
et al., 2008). Numerous studies have established an essential
role of tumor necrosis factor (TNF), lymphotoxin (LT), and
CXCL13 in the development of FDCs because mice deficient
for these molecules or their receptors exhibit severe defects in
FDC network formation and GC development (Allen et al., 2004;130 Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc.Ansel et al., 2000; Cyster et al., 2000; Forster et al., 1996; Fu
and Chaplin, 1999; Pasparakis et al., 1996; Victoratos et al.,
2006). Lessons from lymphoid neogenesis support the notion
that the significance of FDCs in the generation of protective
T cell-dependent humoral responses is likely to extend to B cell
autoimmune responses (Aloisi and Pujol-Borrell, 2006; Drayton
et al., 2006). In the course of many autoimmune disorders, the
accumulation of lymphoid cells in the inflamed tissues estab-
lishes microenvironments that are rich in organogenic and
inflammatory cytokines driving a lymphoid-like chemoattractive
milieu. In such microenvironments, the ectopic development of
FDC networks harboring autoreactive GCs seems inevitable.
Evidently,25%of patientswith rheumatoid arthritis (RA) display
all facets of highly ordered tertiary lymphoid structures, including
follicular areas with FDCs, GC B cells, and ongoing affinity matu-
ration (Kim et al., 1999; Takemura et al., 2001). Although the
presence of FDCs correlates with ectopic GC formation, no
conclusive data have elucidated whether FDCs act as causal-
effector cells of the disease or whether their ectopic generation
is a bystander autoimmune event. Thus, a functional implication
of FDCs in the initiation of autoimmune disorders needs to be
explored.
A major reason why a potential role of FDCs in autoimmunity
has not been pursued is that appropriate models would have
to confront the complexity of FDC maturation by targeting mole-
cules that are also instrumental in inflammatorymanifestations of
autoimmune diseases. In addition, the pathogenic mechanisms
of a disease model that would permit convenient analysis of
FDC-mediated functions should ideally be readily distinguish-
able and independently reproducible in vivo. We have chosen
to examine the role of FDCs in the K/BxN model of spontaneous
arthritis that has many of the clinical, histological, and immuno-
logical features of rheumatoid arthritis in humans (Korganow
et al., 1999; Kouskoff et al., 1996). K/BxN mice, which were
originally generated by the crossing of KRN T cell receptor-
transgenic mice on C57BL6/J genetic background (K/B) with
NOD mice, develop an aggressive form of arthritis that begins
at 3–4 weeks of age. Disease proceeds from three sequential
events: a break of tolerance leads to the activation of adaptive
immunity resulting in the production of arthritogenic autoanti-
bodies (inductive phase) with subsequent autoantibody-
mediated activation of innate immunity (effector phase). Initially,
KRN CD4+ T cells escape from clonal deletion in the thymus and
mature T cells appear in the periphery at 3 weeks of age, albeit in
reduced numbers (Kouskoff et al., 1996). In the context of I-Ag7
molecule (Kouskoff et al., 1996), the KRN T cell receptor (TCR)
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FDCs in Arthritisrecognizes glucose-6-phosphate isomerase (GPI) (Basu et al.,
2000; Matsumoto et al., 1999), a ubiquitously expressed self-
antigen that is also present on the surface of inflamed joints (Mat-
sumoto et al., 2002;Wipke et al., 2002). PrimedKRNCD4+ T cells
collaborate with GPI-reactive B cells for the production of high
titers of GPI antibodies, mainly of IgG1 isotype. Autoantibody-
mediated inflammatory mechanisms are the hallmark features
of the downstream effector phase of the disease (Corr and Crain,
2002; Ji et al., 2002a; Lee et al., 2002; Wipke and Allen, 2001).
These mechanisms include activation of the alternative comple-
ment pathway and signaling though Fc receptors that trigger the
secretion of inflammatory cytokines and degradative enzymes
from neutrophils, mast cells, and macrophages. Transfer of
serum from diseased mice can elicit the complete range of
articular manifestations that underlie the effector phase of the
disease (Korganow et al., 1999). In addition, adoptive transfer
of splenocytes or CD4+ T cells from healthy K/B donors into
mice of BxG7 genetic background recapitulates both the induc-
tive and the effector phase of the disease (Korganow et al.,
1999).
We have recently described an FDC-specific system that is
composed of a CD21-Cre:loxP-mediated recombination of
a p55TNFRgain-of-function allele and abonemarrow reconstitu-
tion (Victoratos et al., 2006). That approach revealed the cell-
autonomous function of p55TNFR in the maturation of FDCs,
because reactivation of p55TNFR in FDCs results in restoration
of FDC clustering and GC formation. Here, an adaptation of
that approach operates as a p55TNFR-dependent switch of
FDC maturation with minimal interference in potential
p55TNFR-mediated inflammatory cascades. To identify the func-
tional implications of FDC networks in autoantibody-mediated
spontaneous arthritis, we combined the transfer systems of
K/BxN arthritis with this FDC-specific genetic tool. We found
that FDCs were essential for autoreactive GC reactions and the
production of arthritogenic antibodies. In the presence of
FDCs, autoreactive Tfh cells migrated into lymphoid follicles to
provide cognate help to B cells, in a process that depends on
CXCR5 expression on Tfh cells. Notably, immune complex
deposition on FDCs enhanced B cell autoreactivity by upregula-
tion of Bcl6, resulting in endorsement of GC reactions, increased
autoantibody secretion, and finally exacerbation of arthritis.
Furthermore, pharmacological intervention in the maintenance
of FDC networks attenuates GC formation and autoantibody
production with consequent amelioration of the disease.
RESULTS
Switching Off and On the Formation of FDCs
in Spontaneous Arthritis
We showed previously that CD21 (encoded by Cr2)-Cre-
mediated recombination is restricted in FDCs after bone marrow
transfer and reactivates a gain-of-function p55TNFR conditional
allele (Tnfrsf1acneo), resulting in the appearance of functional
FDC networks (Victoratos et al., 2006). In the present study,
bone marrow cells from normal (C57BL/6JxB6.H2g7) F1 hybrids
(hereafter called BxG7) were transferred to lethally irradiated
Tnfrsf1a+/+,Tnfrsf1a/,Tnfrsf1acneo/, andCr2-CreTnfrsf1acneo/
mice of BxG7 background, resulting in Tnfrsf1a+/+BxG7,
Str-FDC-Tnfrsf1a/BxG7, Str-FDC-Tnfrsf1acneo/BxG7, andStr-Tnfrsf1acneo/BxG7 chimeras, respectively. The abbrevia-
tions ‘‘Str-’’ and ‘‘Str-FDC-’’ are used to describe the achieved
state of Tnfrsf1a alleles (encoding p55TNFR) in non-FDC stroma
cells or in non-FDC stroma cells plus FDCs, respectively. For
instance, ‘‘Str-FDC-Tnfrsf1acneo/BxG7’’ indicates a chimeric
mouse of BxG7 background with one nonrecombined condi-
tional and one null Tnfrsf1a allele in both non-FDC stroma cells
and FDC cells (see Table S1, available online, for detailed
description). The above bone marrow reconstitution approach
preserves the expression of I-Ag7 that is required for GPI recogni-
tion and restores the expression of p55TNFR in the hematopoi-
etic compartment of all chimeras. However, these chimeras
display differential compartmentalization of p55TNFR deficiency
in FDCs and non-FDC stroma cells, with consequent discrep-
ancies in the development of FDC networks: normal chimeras
displaying FDC networks (Tnfrsf1a+/+BxG7), chimeras that lack
p55TNFR on FDCs and non-FDC stroma resulting in the absence
of FDCs (Str-FDC-Tnfrsf1a/BxG7 and Str-FDC-Tnfrsf1acneo/
BxG7 chimeras), and chimeras with non-FDC stroma
p55TNFR-dificiency but with established FDC networks (Str-
Tnfrsf1acneo/BxG7 chimeras). Potential contributions of
p55TNFR deficiency in non-FDC stroma cells, homeostatic
differences, or the conditional Tnfrsf1acneo allele to a particular
parameter of the disease that could lead to an FDC-unrelated
effect are consistently addressed by crossexamination of the
four chimeras.
To identify a potential role of FDCs in the development of
arthritis, we injected splenocytes from healthy K/B donors
(KRN-transgenic mice on C57BL/6J background) into the above
chimeras, an arthritis-transfer system that recapitulates induc-
tive and effector phases of the disease. To improve the engraft-
ment of K/B splenocytes, we irradiated chimeras with a sublethal
dose of irradiation that had relatively minimal cytotoxic effects
on the hematopoietic compartment of the hosts (Figure S1).
Transfer of K/B splenocytes into Tnfrsf1a+/+BxG7 and Str-
Tnfrsf1acneo/BxG7 chimeras that differ in p55TNFR deficiency
in non-FDC stroma cells, but display FDC networks, resulted in
the development of arthritis in both groups of recipients (Fig-
ure 1A). Mice with p55TNFR deficiency in non-FDC stroma cells
and FDCs, including Str-FDC-Tnfrsf1a/BxG7 and Str-FDC-
Tnfrsf1acneo/BxG7 chimeras in which FDC networks are absent,
were resistant to the development of disease. Histological anal-
ysis of joints confirmed differences in the clinical manifestations
of the disease (Figure 1B and Figure S2). In Tnfrsf1a+/+BxG7 and
Str-Tnfrsf1acneo/BxG7 chimeras that received K/B splenocytes,
disease was marked by hyperplastic synovium with massive
infiltration of inflammatory cells, typical pannus formation, carti-
lage destruction, and bone erosion. On the contrary, thesemani-
festations of arthritis were absent in Str-FDC-Tnfrsf1a/BxG7
and Str-FDC-Tnfrsf1acneo/BxG7 chimeras treated with K/B
splenocytes. Taken together, these results suggest that FDCs
are important for the development of autoantibody-mediated
spontaneous arthritis.
FDCs Are Important for the Inductive Mechanisms
of the Disease
To assess the contribution of effector mechanisms in disease
disparity among chimeras, we treated BxG7 chimeras with
arthritogenic serum from K/BxG7 mice (KRN-transgenic miceImmunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc. 131
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FDCs in ArthritisFigure 1. Lack of FDC Networks Prevents the Development of Autoantibody-Mediated Spontaneous Arthritis
Lethally irradiated Tnfrsf1a+/+, Tnfrsf1a/, Tnfrsf1acneo/, andCr2-Cre-Tnfrsf1acneo/mice of BxG7 genetic background received bonemarrow cells from normal
BxG7 mice. Two months later, the above chimeras (Tnfrsf1a+/+BxG7, Str-FDC-Tnfrsf1a/BxG7, Str-FDC-Tnfrsf1acneo/BxG7, and Str-Tnfrsf1acneo/BxG7,
respectively) received 15 3 106 splenocytes from B or K/B mice.
(A) Arthritis score of indicated BxG7 chimeras treated with K/B splenocytes. The graph shows mean ± standard error of the mean (SEM). The data are represen-
tative of two independent experiments with 15 mice per group.
(B) Hematoxylin-eosin staining of ankle-joint sections from BxG7 chimeras 30 days after splenocyte transfer from B or K/B mice. The data are representative of
two independent experiments with 15 mice per group.on BxG7 background). Neither chimera showed differences in
the onset, severity, or duration of serum-transfer arthritis after
two injections of arthritogenic serum (Figure S3A). The same
results were obtained when repeated injections of arthritogenic
serum were administered (Figure S3B). The above results show
that the effector mechanisms are intact in all four BxG7 chimeras
and prompted us to investigate potential differences in the
inductive mechanisms. Accordingly, we found that Tnfrsf1a+/+
BxG7 and Str-Tnfrsf1acneo/BxG7 chimeras accumulated high
amounts of arthritogenic aGPI IgG antibodies compared to132 Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc.Str-FDC-Tnfrsf1a/BxG7 and Str-FDC-Tnfrsf1acneo/BxG7
chimeras in response to transfer of splenocytes from K/B mice
(Figure 2A). Isotype analysis revealed that arthritogenic anti-
bodies were mainly IgG1 (Figure 2B). In Tnfrsf1a+/+BxG7 and
Str-Tnfrsf1acneo/BxG7 chimeras, the transfer of K/B spleno-
cytes induced a strong GC reaction, with GC B cells efficiently
undergoing isotype switching toward GPI-reactive IgG1+ cells
(Figure 2C). Kinetics on the numbers of splenic and inguinal LN
GC B cells showed that GCs were already induced 7 days after
the transfer of K/B splenocytes and reached maximum number
Immunity
FDCs in ArthritisFigure 2. FDCs Are Important for the Inductive Phase of Autoantibody-Mediated Spontaneous Arthritis
(A) Kinetics of aGPI IgG production.
(B) Isotype profile of arthritogenic antibodies on day 21 in BxG7-chimeras that received K/B splenocytes. Data are representative of two independent experiments
(mean ± SEM of fifteen mice per group).
(C) B or K/B splenocytes were transferred to BxG7-chimeras and spleens were analyzed for GC B cells 14 days after the transfer. GC B cells were identified as
B220+GL7+CD95+ cells. The frequency of GC B cells that had undergone IgG1 isotype switching was determined as B220+GL7+CD95+IgG1+ cells.
B220+GL7+CD95+IgG1+ cells were further analyzed for GPI-binding activity (histogram; red line). B220+GL7+CD95+IgG1+ cells that were induced 10 days after
immunization with SRBCs were used as negative control of GPI-binding activity (histogram; black line). Data show means ± SEM of two experiments with five
mice per group and numbers adjacent to outline areas indicate the frequency of cells in each gate.
(D) Immunofluorescence of spleens from BxG7-chimeras treated with B or K/B splenocytes. We obtained cryostat sections 14 days after cell transfer and stained
themwith anti-CD35 (blue), anti-GL7 (green), and anti-B220 (red) to visualize FDC networks, GCs, and B lymphocytes, respectively (original magnification 2003).
Data are representative of one experiment with many splenic sections from five mice per group.Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc. 133
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FDCs in Arthritisby day 14 (Figure S4). In sharp contrast, Str-FDC-Tnfrsf1a/
BxG7 and Str-FDC-Tnfrsf1acneo/BxG7 chimeras lacking FDC
networks exhibited severe defects in the induction of GCs
followed by impaired production of arthritogenic antibodies in
response to K/B splenocyte transfer. Examination of spleens
confirmed that GC reactions occurred in the vicinity of FDCs
and within lymphoid follicles in Tnfrsf1a+/+BxG7 and Str-
Tnfrsf1acneo/BxG7 chimeras (Figure 2D). In contrast, GC reac-
tivity was absent in Str-FDC-Tnfrsf1a/BxG7 and Str-FDC-
p55TnfRcneo/BxG7 chimeras. Taken together, these results
demonstrate an essential function of FDCs in the development
of autoreactive GCs that lead to the production of arthritogenic
antibodies during the inductive phase of the disease.
Recruitment of Arthritogenic Tfh Cells into the
Lymphoid Follicles Depends on the Integrity
of FDC Networks
To evaluate the necessity for an FDC-dependent function of au-
toreactive CD4+ T lymphocytes, we transferred carboxyfluores-
cein succinimidyl ester (CFSE)-labeled K/B splenocytes into
BxG7 chimeras. B chimeras that were generated by transfer of
bone marrow cells from normal mice of B background to lethally
irradiated mutant mice of B background were used as controls
(Figure 3A). Although CD4+ K/B cells did not divide after transfer
into control B chimeras, substantial division took place when
they were introduced into BxG7 chimeras. We observed no
substantial difference in CD4+ K/B accumulation, indicating
that cell trafficking toward secondary lymphoid organs was not
affected in the four B chimeras. Moreover, we observed similar
proliferation of CD4+ K/B cells in the four BxG7 chimeras, sug-
gesting that the FDC-dependent differences in the development
of disease should not be attributed to differential T cell priming. In
order to make them permanently traceable, we injected purified
eGFP+CD4+ K/B cells into the four B or BxG7 chimeras. These
eGFP+CD4+ K/B cells showed no substantial difference in their
capacity to differentiate toward CXCR5hiICOShi Tfh cells in the
context of the presence or the absence of FDCs (Figure 3B).
The same results were obtained when additional markers of
Tfh cells were included in the analysis (Figure S5).
Alternatively, defective migration of autoreactive CXCR5hi
ICOShi Tfh cells into B cell areas may result in insufficient
T-B cell collaboration for the generation of GCs. Spleens from
the above BxG7 chimeras were examined for the subcompart-
mentalized distribution of autoreactive eGFP+CD4+ K/B cells.
In Tnfrsf1a+/+BxG7 and Str-Tnfrsf1acneo/BxG7 chimeras, we
observed a substantial number of eGFP+ cells in B cell follicles
and adjacent to FDCs (Figure 3C). Although the time point of
day 7 was quite early (Figure S4), GC reactions were already
noticeable (Figure 3C). In contrast, eGFP+ cells remained in
the T cell zones of Str-FDC-Tnfrsf1a/BxG7 and Str-FDC-
Tnfrsf1acneo/BxG7 recipients. The CD4+ identity of eGFP+ cells
was confirmed by flow cytometry and immunofluorescence
(Figure S6).
We then isolated eGFP+CD4+ K/B cells from mice with or
without CXCR5 deficiency and transferred them into normal
BxG7 mice. Although recipients displayed FDC networks,
CXCR5-deficient CD4+ K/B cells remained outside lymphoid
follicles compared to control CD4+ K/B cells (Figure 4A). The
defective migration of autoreactive CXCR5-deficient T lympho-134 Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc.cytes was concomitant with defective GC reactions (Figure 4B),
reduced production of autoantibodies (Figure 4C), and ameliora-
tion of the disease (Figure 4D). Of note, CXCR5-deficient CD4+
K/B cells exhibited no marked defects in proliferation or activa-
tion compared to control CD4+ K/B cells (Figure S7). Taken
together, these results suggest that the differentiation and
CXCR5-dependentmigration of arthritogenic Tfh cells are critical
steps in disease pathology and the integrity of FDC networks is
essential for the relocation of Tfh cells into follicles.
Immune Complex Deposition on FDCs Enhances
the Development of Autoreactive GCs
The pivotal role of FDCs in disease manifestation through the
recruitment of Tfh cells into lymphoid follicles cannot rule out
a direct FDC-mediated endorsement of B cell autoreactivity.
To test this, we injected immune complexes (ICs), which were
composed of autoantibodies and GPI (aGPI-GPI), intravenously
(i.v.) into normal BxG7 mice. A second group of BxG7 mice was
treated with an equivalent amount of arthritogenic serum.
Although arthritogenic serum provoked an acute inflammatory
reaction, mice treated with aGPI-GPI showed no signs of
disease (Figure 5A). When the transfer of splenocytes from K/B
donors followed the injection of aGPI-GPI, recipients developed
an aggravated disease compared to mice injected with spleno-
cytes alone. The exacerbation of the disease was strongly asso-
ciated with enhanced GC reaction (Figure 5B) and autoantibody
production (Figure 5C). A potential scenario for the IC-mediated
exacerbation of the disease could be that aGPI-GPI is captured
by professional antigen-presenting cells (APCs), resulting in
enhanced priming and differentiation of autoreactive CD4+ K/B
cells. However, in vivo, autoreactive CD4+ K/B cells exhibited
comparable proliferating, differentiating, and lymphoid follicle
migratory capacities in the presence or the absence of aGPI-
GPI treatment (Figure S8), suggesting that endogenous GPI is
sufficient for thorough T cell activation and that enhanced
disease could be attributed to T cell-independent augmentation
of B cell autoreactivity.
To track down ICs, we treated mice with a traceable form that
consisted of autoantibodies and biotin-conjugated GPI (aGPI-
b-GPI). The examination of spleen sections showed that FDC
networks were heavily loaded with b-GPI after 24 hr of aGPI-
b-GPI treatment (Figure S9). The specificity of IC deposition on
FDCs was further confirmed in aGPI-b-GPI-treated p55TNFR-
deficient mice, whereas no depots of b-GPI were detected in
the absence of FDCs. In agreement with the above results
showing a robust GC reaction in response to aGPI-GPI treatment
(Figure 5B), we detected substantial GC formation adjacent to
IC-loaded FDC networks 4 days after the injection of aGPI-
b-GPI and K/B splenocytes (Figure S10A). In contrast, injection
of K/B splenocytes alone resulted in relatively delayed GC
formation. Notably, IC-loaded FDCs colocalized with GCs in
mice treated with aGPI-b-GPI alone, but this GC reactivity was
short-lived (Figure S10B) and not productive (Figure 5C). These
results suggested a T cell-independent, FDC-dependent fashion
of IC-driven generation of GCs because central tolerance typi-
cally eliminates a GPI-reactive T cell repertoire in normal BxG7
mice. To stringently address this issue, we injected aGPI-
b-GPI ICs into Tcrb/Tcrd/ mice of B genetic background
that completely lack T lymphocytes. In the absence of
Immunity
FDCs in ArthritisFigure 3. Impaired Migration of Arthritogenic Tfh Cells into B Cell Regions in the Absence of FDCs
(A) CFSE-labeled splenocytes from K/B mice were transferred to B chimeras (upper panel) or BxG7 chimeras (lower panel). Three days later, cell division was
measured as dilution of CFSE intensity in CD4+ splenocytes. Numbers (mean ± standard deviation [SD]) indicate the frequency of cells in each gate. Data are
representative of two independent experiments with five mice per group.
(B) Purified eGFP+CD4+ K/B splenocytes were transferred to B or BxG7 chimeras. Seven days after cell transfer, eGFP+CD4+ splenocytes were analyzed by flow
cytometry for determination of CXCR5hiICOShi arthritogenic Tfh cells. Numbers (mean ± SD) indicate the frequency of cells in eGFP+CD4+CXCR5hiICOShi gate.
Data are representative of two independent experiments with five mice per group.
(C) Purified eGFP+CD4+ K/B cells were transferred into BxG7 chimeras for analysis of the location of arthritogenic T lymphocytes. Splenic cryostat sections
obtained 7 days after cell transfer were stained with anti-B220 (B cell regions; red) and CD35 (FDCs; blue) or anti-GL7 (GCs; red) and anti-B220 (B cell regions;
blue) (original magnification 2003). Data are representative of two independent experiments with five mice per group.Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc. 135
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FDCs in ArthritisFigure 4. Impaired Arthritogenicity of CXCR5-Deficient CD4+ Cells in a Normal Lymphoid Environment
(A) eGFP+CD4+ from Cxcr5+/+K/B or Cxcr5/K/B mice were transferred into BxG7 chimeras. Splenic cryostat sections obtained 7 days after cell transfer were
stained with anti-B220 (B cell regions; red or blue) and CD35 (FDCs; blue) (original magnification 2003). Data are representative of two independent experiments
with ten mice per group.
(B–D) CD4+ cells fromCxcr5+/+K/B orCxcr5/K/Bmicewere transferred to normal BxB or BxG7mice. In (B), spleenswere analyzed for GCB cells on day 14 after
the transfer. GC B cells were identified as B220+GL7+CD95+ cells. In (C), sera that were collected from the above recipients on day 21 were assayed for aGPI IgG
production. (D) shows disease development in indicated recipients. The graphs showmean ± SEM. Data are representative of two independent experiments with
ten mice per group.T lymphocytes, IC-loaded FDCs still harbored short-lived GC
B cells (Figure S10B). Because the transcription factor Bcl6 is
the master regulator of the GC-phenotype commitment of
B cells, we assayed for the expression of this transcription factor
in Tcrb/Tcrd/ mice. Under these T cell-independent condi-
tions and upon treatment with aGPI-GPI, the expression of
Bcl6 was strongly upregulated in GL7+ GC B cells (Figure 5D).
When isolated FDCs were loaded in vitro with aGPI-GPI ICs
and cocultured with B lymphocytes, a substantial number of
B cells acquired a GL7+CD95+Bcl6+ phenotype (Figure 5E).
Collectively, these findings suggest that IC-loaded FDCs are
sufficient to induce Bcl6 expression and a GC B cell phenotype,
resulting in enhanced B cell autoreactivity. However, as shown
above, IC-mediated GC reactivity is short-lived and not produc-
tive, suggesting that T cell help is required for subsequent differ-
entiation steps that lead to autoantibody production.
p75TNFR:Fc Treatment Affects the Integrity of FDCs
and Attenuates Autoantibody Production
The important role of FDCs in the inductive mechanisms of
autoantibody-mediated spontaneous arthritis prompted us to
examine whether drug-mediated inhibition of FDC maintenance136 Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc.results in amelioration of the disease. To this end, we chose
p75TNFR:Fc (Etanercept) because of its well-recognized
therapeutic efficacy in RA and its compatibility with the murine
system of TNF. Normal mice of BxG7 genetic background
were pretreated with p75TNFR:Fc before the induction of, as
well as during the course of, the disease (Figure 6A). Treatment
with p75TNFR:Fc rapidly affected the integrity of FDC networks
(Figure 6B and Figure S11A), an effect that was durable
throughout the course of the disease (Figure S11B). p75TNFR:
Fc-untreated mice developed arthritis starting 7 days after the
transfer of K/B splenocytes (Figure 6C). In contrast, treatment
with p75TNFR:Fc resulted in disease amelioration documented
by a 7 day delay in the initiation and reduction in the severity of
the disease. Disease alleviation was strongly associated with
attenuation in the induction of GC reactions (Figure 6D) and
diminished autoantibody production (Figure 6E). Moreover, we
examinedwhether additional effects on the effectormechanisms
had contributed to p75TNFR:Fc-mediated amelioration of
the disease. Normal mice of BxG7 genetic background were
injected with arthritogenic serum from K/BxG7 mice with or
without receiving p75TNFR:Fc (Figure 6F). We found that
p75TNFR:Fc had an insignificant effect on the severity and the
Immunity
FDCs in ArthritisFigure 5. Treatment with aGPI-GPI Immune Complexes Exacerbates the Development of Autoantibody-Mediated Spontaneous Arthritis
(A) Development of arthritis in normal BxG7 mice that received i.v. 200 ml of aGPI serum from K/BxG7; aGPI-GPI ICs equivalent to 200 ml of K/BxG7 serum; K/B
splenocytes; or aGPI-GPI ICs and K/B splenocytes. Graph shows mean ± SEM of 15 mice per group. Data are representative of two independent experiments.
(B and C) Kinetics of the generations of GC B cells (B220+GL7+CD95+) by flow cytometry ([B] mean ± SEM of five mice per group), and serum aGPI IgG concen-
trations ([C] mean ± SEM of ten mice per group). Data are representative of two independent experiments.
(D) Normal BxG7mice and Tcrb/Tcrd/mice of BxB background were injected i.v. with aGPI-GPI ICs. Splenic sections obtained 2, 4, or 9 days after treatment
were stained with anti-Bcl6 (green), anti-GL7 (GC B cells; red), and anti-CD35 (FDCs; blue) (original magnification 2003). Data are representative of two
independent experiments.
(E) B cells were cultured with FDCs that had been loaded with aGPI-GPI ICs, and 3 days later cells were analyzed for GC phenotype (B220+GL7+CD95+ cells) and
the expression of Bcl-6 in non-GC B cells and GC-B cells. Data are representative of two independent experiments.Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc. 137
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FDCs in ArthritisFigure 6. p75TNFR:Fc-Mediated Effects on the Maintenance of FDCs Ameliorates the Development of Arthritis
(A) Protocol of treatment with p75TNFR:Fc. Normal BxG7mice were treated intraperitoneally with 200 mg of p75TNFR:Fc every 3 days starting on day6. On day
1, aGPI-GPI ICs were injected i.v., followed by transfer of B or K/B splenocytes (day 0).
(B) Spleenswere collected fromp75TNFR:Fc-treated and control mice at day 0 and subjected to immunostaining for visualization of FDCs (CD35; blue) andB cells
(B220; brown) (original magnification 403). Data are representative of two independent experiments with five mice per group.
(C) Arthritis score was monitored for 30 days after the transfer of B or K/B splenocytes in p75TNFR:Fc-treated and control mice. Data are representative of two
independent experiments with 15 mice per group.
(D) On day 14, spleens from the above group of mice were analyzed by flow cytometry for the frequency of B220+GL7+CD95+ GC B cells. Data are representative
of two independent experiments with five mice per group.
(E) Sera collected on day 21 from the above groups of mice were assayed for aGPI IgG production. Graphs show mean ± SEM. Data are representative of two
independent experiments with 15 mice per group.
(F) Normal mice of BxG7 background were injected i.p. with 200 ml of arthritogenic serum from K/BxG7 mice (black arrows) and 200 mg of p75TNFR:Fc (blue
arrows). Control mice received only 200 ml of arthritogenic serum. Arthritis wasmeasured every 2 days (mean ± SEM). Data are representative of two independent
experiments with ten mice per group.course of passively transferred disease. These findings show
that drug-mediated disruption of FDC maintenance can inhibit
GC reactions and subsequent autoantibody production, result-
ing in disease alleviation.
DISCUSSION
Activation of adaptive immune responses is thought to be an
intrinsic component of organ-specific autoimmune diseases.
The persistent activation and collaboration of T and B lympho-
cytes that associate with enduring circulation of autoantibodies
and the successful therapeutic intervention of B cell depletion
in RA (Cohen et al., 2006) emphasize the pivotal role of patho-
genic B cell responses in several immune disorders (Edwards138 Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc.and Cambridge, 2006; Martin and Chan, 2006). Although the
presence of FDCs correlates with ectopic GC formation in the
inflamed tissues, the role of FDCs as a relevant cell type linking
B cell autoreactivity with disease development has remained
elusive. Here, we showed that FDCs are important for the path-
ogenic B cell reactivity through autoantigen-containing ICs and
the recruitment of arthritogenic Tfh cells into lymphoid follicles
with immunologically relevant consequences, such as the insti-
gation of autoantibody-mediated spontaneous arthritis.
To achieve a differential compartmentalization of p55TNFR
deficiency,weusedasetofgenetic tools that led to thegeneration
of four chimericmice with or without FDC networks. Downstream
effector mechanisms following the production of autoantibodies
remained intact among these chimeras because transfer of
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termsofonset, severity, andduration. Thus, in thecontextof auto-
antibody-mediated spontaneous arthritis, p55TNFR-mediated
effector mechanisms on stroma cells seem to be less critical for
disease pathology. This is in agreement with previous studies
showing that TNFand its receptors are not essential for the serum
transfer of K/BxN arthritis (Ji et al., 2002b; Kyburz et al., 2000),
suggesting a dominant role for IL-1 in tissue damage during
IC-mediated arthritis in mice (Ji et al., 2002b; Van Lent et al.,
1995). Although p55TNFR expression on stroma cells was not
essential for the effector phase, p55TNFR-mediated integrity of
FDC networks was important for the inductive mechanisms of
the disease. Transfer of arthritogenic cells rapidly induced an
ongoing autoreactive GC reaction in chimeras with functional
FDCs before the onset of the disease. GC reaction was followed
by the appearance of serum arthritogenic antibodies leading to
tissuedamage. In theabsenceofFDCs, recipientswere refractory
to arthritis because GC reactions were suppressed and the
production of arthritogenic antibodies was diminished.
Although central tolerance removes a large proportion of
a self-reactive B cell repertoire, autoreactive B cells still consti-
tute a substantial proportion of the mature B cell compartment
in healthy individuals. Because most B cell responses depend
on collaboration with T cells, an important checkpoint to prevent
the generation of autoreactive long-lived plasma cells and
memory B cells must be the prevention of activated self-reactive
T cells from acquiring a follicular phenotype and entering follicles
or helping autoreactive GC B cells. Sanroque mice provide the
strongest link between Tfh cells and autoimmunity (Vinuesa
et al., 2005; Yu et al., 2007). In these mice, a point mutation in
the roquin (Rc3h1) gene deregulates the expression of the costi-
mulatory molecule inducible costimulator (ICOS), resulting in the
abnormal expansion of Tfh cells. Consequently, sanroque mice
develop systemic lupus erythematosus (SLE)-like disease and
autoimmune diabetes, both of which are associated with accu-
mulation of Tfh cells in the follicles, increased GC reactions,
and high concentrations of autoantibodies.
Tfh cells that upregulate CXCR5 upon activation are localized
into lymphoid follicles in response to CXCL13 (Ansel et al., 1999).
Importantly, adoptively transferred CXCR5-deficient T cells are
excluded from lymphoid follicles, signifying the indispensable
role of CXCR5 on Tfh cells for follicular localization and antibody
production (Hardtke et al., 2005; Junt et al., 2005). The present
study underscores the significance of Tfh cells in pathology
because arthritogenic CD4+ cells acquired a Tfh phenotype
and migrated into lymphoid follicles. Furthermore, arthritogenic
T cells with deficiency in CXCR5 were disqualified from popu-
lating lymphoid follicles, resulting in compromised GC reactions,
reduction of autoantibodies, and, finally, disease alleviation. FDC
networks were vital for this critical step of disease pathology
because arthritogenic Tfh cells remained in T cell regions in the
absence of FDCs. FDCs are the major source of follicular
CXCL13 (Ansel et al., 2000), and the FDC-derived CXCL13 is
sufficient for the CXCR5-mediated recruitment of Tfh cells (Estes
et al., 2004). However, the relative contribution of other follicular
stroma cells to CXCL13 production cannot formally be excluded.
In this context, our results suggest that the integrity of FDC
networks establishes the appropriate CXCL13 gradient that
relocates arthritogenic Tfh cells into follicles.Typically, a productive GC reaction is an FDC- and T cell-
dependent process, but initial stages of GC formation can
proceed in the absence of T cells (de Vinuesa et al., 2000; Lentz
and Manser, 2001; Toellner et al., 2002). These T cell-indepen-
dent (TI) GCs are located in lymphoid follicles and containmature
FDCs, IC deposits, and B cells that display the phenotypical
virtues of conventional GC B cells. A strong multivalent engage-
ment of B cell receptors (BCRs) alone is sufficient to induce TI GC
clusters, but T cells are obligatory for intermediate and later
stages of GC reaction because TI GCs resolve when GC B cells
acquire support from T cells. In the present study, autoantigen-
containing ICs initiated a short-lived GC reaction that was not
productive in the absence of T cells, and thus recipients were
refractory to disease. We cannot rule out the possibility that the
initial engagement of BCR with autoantigen in the form of ICs
occurs extrafollicularly, and thus founder GC B cells migrated
into follicles to form GC structures. However, IC-induced GCs
were located exclusively in the vicinity of IC-bearing FDCs, sug-
gesting that the FDC-dependent delivery of autoantigen to
founder GC B cells or newly recruited B cells promoted further
the initial formation of GCs. In addition, the acquisition of a GC
B cell phenotype in the absence of T cells was strongly associ-
ated with the upregulation of Bcl6, and IC-loaded FDCs were
sufficient to upregulate Bcl6. In that regard, our data propose
that the deposition of ICs on FDCs provides niches for sustained
autoantigen engagement that promote Bcl6 expression and GC
B cell phenotype. Together with the FDC-dependent recruitment
of arthritogenic Tfh into follicles that ensures T cell help, GC
B cells accomplish their differentiation toward autoantibody-
producing cells, and arthritis is established.
The functional implication of FDCs in the development of
autoantibody-mediated spontaneous arthritis suggests that
drugs interfering with the maintenance and/or the function of
FDCs could ameliorate disease development. In a previous
study, inhibition of TNF and LT signaling by administration of
agents, including LTbR-Ig, anti-LTb, and p55TNFR-Ig, led to
the disappearance of FDCs and prevented trapping of immune
complexes (Mackay andBrowning, 1998). Moreover, pharmaco-
logical administration of LTbR-Ig reduced the severity of
collagen-induced arthritis (Fava et al., 2003). However, the phys-
iological significance of LTbR-Ig-mediated disruption of FDCs in
collagen-induced arthritis was compromised by the broad
effects of the treatment, such as the systemic responses of
M. tuberculosis-containing adjuvant, T cell responses, and
severe non-FDC-related alterations in lymphoid architecture
and in homeostasis. To a certain degree, clinical results reaf-
firmed the efficacy of anti-TNF or LTa in disruption of FDC
networks; RA patients on p75TNFR:Fc treatment displayed
defective FDC formation (Anolik et al., 2008). However, in the
same study, there has been no direct evidence for the involve-
ment of FDCs in the generation of arthritogenic B cell responses,
and the relative contribution of othermechanisms or cell types on
p75TNFR:Fc-mediated effects has remained elusive. Here, the
effector mechanisms of the disease, the production of autoanti-
bodies, and the homing, priming, and expansion of arthritogenic
T lymphocytes were parameters that were not affected by
p55TNFR deficiency on non-FDC stroma cells. On the contrary,
the p55TNFR-dependent integrity of FDCs was critical for the
generation and propagation of GC B cells by immune complexesImmunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc. 139
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Furthermore, we showed that p75TNFR:Fc-mediated inhibition
of FDC maintenance decreased GC formation and autoantibody
production with subsequent amelioration of autoantibody-medi-
ated spontaneous arthritis. Accordingly, our findings suggest
that drug-mediated disruption of FDCmaintenance and function
could have a beneficial impact on autoimmune diseases.
RA is a widespread autoimmune disease of unknown etiology.
Intensive research with different murine models has pinpointed
individual molecular and cellular mechanisms that integrate
into human disease pathology. The successful therapeutic
responses following B cell depletion support the concept that
in many RA patients, disease critically depends on T-B interac-
tions, autoantibody production, and immune complexes. The
K/BxNmurinemodel of spontaneous arthritis illuminates autoan-
tibody-mediated mechanisms underlying disease pathology. In
the crossroads of these destructive mechanisms of autoimmu-
nity, FDCs are important for the generation of GC responses
and production of autoantibodies. An important implication of
our observations is that compounds designed to inhibit the
maintenance and/or the function of FDCs have the potential to
diminish the severity of antibody-mediated autoimmune disor-
ders, such as rheumatoid arthritis.
EXPERIMENTAL PROCEDURES
Mice
Cr2-Cre-transgenic (tg) mice (Kraus et al., 2004; Victoratos et al., 2006),
Tnfrsf1acneo/cneo mice (Victoratos et al., 2006), Tnfrsf1a/ mice (Rothe et al.,
1993), and the Z/EG reporter line (Novak et al., 2000) have been described.
KRN TCR tg mice (Kouskoff et al., 1996) were maintained on the C57BL/6J
background (K/Bmice). Crossing of these K/Bmice with B6.H-2g7/g7 congenic
line generates arthritic K/BxG7 offspring, which resemble K/BxNOD in all
aspects of the disease (Kouskoff et al., 1996). C57BL/6J-Tcrbtm1Mom
Tcrdtm1Mom (Tcrb/Tcrd/) and C57BL/6J-Cxcr5tm1Lipp (Cxcr5/) mice
were obtained from the Jackson Laboratory.
Bone marrow chimeras were generated as previously described (Victoratos
et al., 2006). In brief, bone marrow cells (13 106 cells per mouse) from normal
B or (BxG7)F1mice were injected i.v. into lethally irradiatedmutant mice of B or
(BxG7)F1 genetic background, respectively. B and BxG7 chimeras were used
2–2.5 months after reconstitution. All mice were used in accordance with the
guidance of the Institutional Animal Care and Use Committee of BSRC
‘‘Alexander Fleming.’’
Active and Passive Transfer of Arthritis
For active induction of disease, cell suspensions were prepared from pooled
spleens followed by depletion of erythrocytes. Splenocytes (15 3 106 per
mouse) were injected i.v. into recipients that had received 250 rads of irradia-
tion 6 hr before the injection. In cases specified, CD4+ splenocytes were puri-
fied by positive selection with CD4 primary antibody and MACS Microbeads
(Miltenyi Biotech) according to the manufacturer’s instructions and transferred
i.v. into recipient mice (1.5 3 106 per mouse). The purity was constantly
measured by flow cytometry.
Passive arthritis was induced as previously described (Korganow et al.,
1999). In brief, arthritogenic serum pools were prepared from 8-week-old
K/BxG7 mice. Arthritis was induced in the recipient mice by injection of 200 ml
serum at indicated days. A clinical score was assigned to each mouse as
described below.
Arthritis Scoring
Arthritic pathology was assessed in a blinded manner as previously described
(Simelyte et al., 2005). In brief, the clinical severity of arthritis was graded for
each paw as follows: 0 = normal; 1 = erythema and swelling of the ankle or wrist
joints and swelling limited to individual digits; 2 = erythema and swelling of the140 Immunity 30, 130–142, January 16, 2009 ª2009 Elsevier Inc.ankle or wrist joints and mid-hindpaw or mid-forepaw areas; and 3 = erythema
and swelling of entire paw, including multiple digits.
Anti-GPI ELISA
Serum levels of anti-GPI Igs were measured as described (Mandik-Nayak
et al., 2002). Optical density values were converted to arbitrary units (AUs)
by comparison to a pool of sera from 8-week-old K/BxG7 mice.
Antigen and Immune Complexes
Rabbit glucose-6-phosphate isomerase (GPI; Sigma-Aldrich) was biotinylated
by EZ-Link Sulfo-NSH-LC-Biotinylation Kit according to the manufacturer’s
instructions (Pierce). Biotin incorporation was 3.6 moles of biotin per mole of
protein.
The production of injected immune complexes was performed at the equiv-
alent point. The amount of injected immune complexes corresponded to 200 ml
of serum and 160 mg of GPI per mouse. For the estimation of the equivalent
point of IC formation, a constant amount of arthritogenic serum from
K/BxG7 mice was incubated for 1 hr at 37C with different amounts of GPI
and then incubated overnight at 4C. Immune complexes were washed twice
with PBS, solubilized in 0.1N NaOH, and measured at 280 nm.
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